• 1
    Levy MJ, Wiersema MJ, Chari ST. Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy 2006; 38 (Suppl. 1): S3035.
  • 2
    Dite P, Novotny I, Trna J, Sevcikova A. Autoimmune pancreatitis. Best Pract. Res. Clin. Gastroenterol. 2008; 22: 131143.
  • 3
    Tan KK, Chen K, Liau KH, Ho CK. Pancreatic tuberculosis mimicking pancreatic carcinoma: series of three cases. Eur. J. Gastroenterol. Hepatol. 2009; 21: 13171319.
  • 4
    Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int. J. Cancer 2013; 132: 11331145.
  • 5
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Cited 15 Sep 2012. Available from URL:
  • 6
    Ros PR, Mortelé KJ. Imaging features of pancreatic neoplasms. JBR-BTR 2001; 84: 239249.
  • 7
    American Cancer Society. Cancer facts and figures 2010. Atlanta: American Cancer Society. 2010. Cited 12 September 2012. Available from URL:
  • 8
    Katanoda K, Dongmei Q. Comparison of time trends in pancreatic cancer incidence (1973–97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. Jpn J. Clin. Oncol. 2008; 38: 165166.
  • 9
    Patil PS, Mohandas KM. Epidemiology of pancreatic cancer in India. In: Shrikhande SV , Büchler M , Friess H , eds. Surgery of Pancreatic Tumors. New Delhi, India: Chapter 9, BI Publications Pvt Ltd, 2008; 111120.
  • 10
    Ministry of Health, Brunei Darussalam. National Cancer Registry, 2007.
  • 11
    Ministry of Health, Malaysia. First report of the National Cancer Registry cancer incidence in Malaysia, 2002. Cited 15 Jun 2010. Available from URL:
  • 12
    Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008; 10: 5862.
  • 13
    Chia KS, Seow A, Lee HP, Shanmugaratnam K. Cancer incidence in Singapore 1993–1997. 2000. Singapore cancer registry report No.5.
  • 14
    Cheng CT, Tsai CY, Hsu JT et al. Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann. Surg. Oncol. 2011; 18: 16061614.
  • 15
    Palazzo L, Roseau G, Gayet B et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25: 143150.
  • 16
    Yasuda K, Mukai H, Nakajima M, Kawai K. Staging of pancreatic carcinoma by endoscopic ultrasonography. Endoscopy 1993; 25: 151155.
  • 17
    Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190: 745751.
  • 18
    Nakaizumi A, Uehara H, Iishi H et al. Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer. Dig. Dis. Sci. 1995; 40: 696700.
  • 19
    Sugiyama M, Hagi H, Atomi Y, Saito M. Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography. Abdom. Imaging 1997; 22: 434438.
  • 20
    Gress FG, Hawes RH, Savides TJ et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest. Endosc. 1999; 50: 786791.
  • 21
    Harrison JL, Millikan KW, Prinz RA, Zaidi S. Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. Am. Surg. 1999; 65: 659664; Discussion 664–5.
  • 22
    Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest. Endosc. 2000; 52: 367371.
  • 23
    DeWitt J, Devereaux B, Chriswell M et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann. Intern. Med. 2004; 141: 753763.
  • 24
    Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin. Gastroenterol. Hepatol. 2006; 4: 717725; Quiz 664.
  • 25
    Klapman JB, Chang KJ, Lee JG, Nguyen P. Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am. J. Gastroenterol. 2005; 100: 26582661.
    Direct Link:
  • 26
    Canto MI, Hruban RH, Fishman EK et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012; 142: 796804; Quiz e14–5.
  • 27
    Bhutani MS, Gress FG, Giovannini M et al. The No Endosonographic Detection of Tumor (NEST) Study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy 2004; 36: 385389.
  • 28
    Hirche TO, Ignee A, Barreiros AP et al. Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy 2008; 40: 910917.
  • 29
    Sakamoto H, Kitano M, Suetomi Y, Maekawa K, Takeyama Y, Kudo M. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med. Biol. 2008; 34: 525532.
  • 30
    Brugge WR, Lee MJ, Kelsey PB, Schapiro RH, Warshaw AL. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest. Endosc. 1996; 43: 561567.
  • 31
    Rosch T, Braig C, Gain T et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102: 188199.
  • 32
    Rosch T, Dittler HJ, Lorenz R et al. [The endosonographic staging of pancreatic carcinoma]. Dtsch. Med. Wochenschr. 1992; 117: 563569.
  • 33
    Rafique A, Freeman S, Carroll N. A clinical algorithm for the assessment of pancreatic lesions: utilization of 16- and 64-section multidetector CT and endoscopic ultrasound. Clin. Radiol. 2007; 62: 11421153.
  • 34
    Horwhat JD, Paulson EK, McGrath K et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest. Endosc. 2006; 63: 966975.
  • 35
    Micames C, Jowell PS, White R et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest. Endosc. 2003; 58: 690695.
  • 36
    Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest. Endosc. 2012; 75: 319331.
  • 37
    Kida M, Araki M, Miyazawa S et al. Comparison of diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration with 22- and 25-gauge needles in the same patients. J. Interv. Gastroenterol. 2011; 1: 102107.
  • 38
    Lee JH, Stewart J, Ross WA, Anandasabapathy S, Xiao L, Staerkel G. Blinded prospective comparison of the performance of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of the pancreas and peri-pancreatic lesions. Dig. Dis. Sci. 2009; 54: 22742281.
  • 39
    Siddiqui UD, Rossi F, Rosenthal LS et al. EUS-guided FNA of solid pancreatic masses: a prospective randomized trial comparing 22-gauge and 25-gauge needles. Gastrointest. Endosc. 2009; 70: 10931097.
  • 40
    Bang JY, Hebert-Magee S, Trevino J, Ramesh J, Varadarajulu S. Randomized trial comparing the 22-gauge aspiration and 22-gauge biopsy needles for EUS-guided sampling of solid pancreatic mass lesions). Gastrointest. Endosc. 2012; 76: 321327.
  • 41
    Cleveland P, Gill KR, Coe SG et al. An evaluation of risk factors for inadequate cytology in EUS-guided FNA of pancreatic tumors and lymph nodes. Gastrointest. Endosc. 2010; 71: 11941199.
  • 42
    Lee JK, Choi ER, Jang TH et al. A prospective comparison of liquid-based cytology and traditional smear cytology in pancreatic endoscopic ultrasound-guided fine needle aspiration. Acta Cytol. 2011; 55: 401407.
  • 43
    LeBlanc JK, Emerson RE, Dewitt J et al. A prospective study comparing rapid assessment of smears and ThinPrep for endoscopic ultrasound-guided fine-needle aspirates. Endoscopy 2010; 42: 389394.
  • 44
    Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest. Endosc. 2005; 62: 728736; Quiz 751, 753.
  • 45
    Krishna NB, Mehra M, Reddy AV, Agarwal B. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Gastrointest. Endosc. 2009; 70: 7079.
  • 46
    Wiersema MJ, Vilmann P, Giovannini M et al. Endosonography guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112: 10871095.
  • 47
    O'Toole D, Palazzo L, Arotcarena R et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest. Endosc. 2001; 53: 470474.
  • 48
    Raut CP, Grau AM, Staerkel GA et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J. Gastrointestinal. Surg. 2003; 7: 118126; Discussion 127–28.
  • 49
    Gress F, Michael H, Gelrud D et al. EUS-guided fine-needle aspiration of the pancreas: evaluation of pancreatitis as a complication. Gastrointest. Endosc. 2002; 56: 864867.
  • 50
    Chang KJ, Nguyen P, Erickson RA et al. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest. Endosc. 1997; 45: 387393.
  • 51
    Eloubeidi MA, Chen VK, Eltoum IA et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am. J. Gastroenterol. 2003; 98: 26632668.
  • 52
    Imaoka H, Yamao K, Bhatia V et al. Rare pancreatic neoplasms: the utility of endoscopic ultrasound-guided fine-needle aspiration-a large sigle center study. J. Gastroenterol. 2009; 44: 146153.
  • 53
    Gress FG, Hawes RH, Savides TJ et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy using linear array and radial scanning endosonography. Gastrointest. Endosc. 1997; 45: 243250.
  • 54
    Fernández-Esparrach G, Ginès A et al. Incidence and clinical significance of hyperamylasemia after endoscopic ultrasound-guided fine needle aspiration of pancreatic lesions: a prospective and controlled study. Endoscopy 2007; 39: 720724.
  • 55
    Affi A, Vazquez-Sequeiros E, Norton ID et al. Acute extraluminal hemorrhage associated with EUS-guided fine needle aspiration: frequency and clinical significance. Gastrointest. Endosc. 2001; 53: 221225.
  • 56
    Eloubeidi MA, Tamhane A. EUS-guided FNA of solid pancreatic masses: a learning curve with 300 consecutive procedures. Gastrointest. Endosc. 2005; 61: 700708.
  • 57
    Thomas T, Kaye PV, Ragunath K, Aithal G. Efficacy, safety and predictive factors for a positive yield of EUS-guided Trucut biopsy: a large tertiary referral center experience. Am. J. Gastroenterol. 2009; 104: 584591.
  • 58
    Wittmann J, Kocjan G, Sgouros SN et al. Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: a prospective study. Cytopathology 2006; 17: 2733.
  • 59
    Yusuf TE, Ho S, Pavey DA et al. Retrospective analysis of the utility of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in pancreatic masses, using a 22-gauge or 25-gauge needle system: a multicenter experience. Endoscopy 2009; 41: 445448.
  • 60
    Gong TT, Hu DM, Zhu Q. Contrast-enhanced EUS for differential diagnosis of pancreatic mass lesions: a meta-analysis. Gastrointest. Endosc. 2012; 76: 301309.
  • 61
    Kitano M, Sakamoto H, Kudo M. Endoscopic ultrasound: contrast enhancement. Gastrointest. Endosc. Clin. N. Am. 2012; 22: 349358.
  • 62
    Ang TL, Teo EK, Ang D, Kwek AB, Fock KM. A pilot study of contrast harmonic endosonography using DEFINITY™ in the evaluation of suspected pancreatic and peri-ampullary malignancies. J. Interv. Gastroenterol. 2011; 1: 160165.
  • 63
    Imazu H, Kanazawa K, Mori N et al. Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma. Scand. J. Gastroenterol. 2012; 47: 853860.
  • 64
    Kitano M, Kudo M, Yamao K et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am. J. Gastroenterol. 2012; 107: 303310.
  • 65
    Imazu H, Uchiyama Y, Matsunaga K et al. Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies. Scand. J. Gastroenterol. 2010; 45: 732738.
  • 66
    Hirooka Y, Itoh A, Kawashima H et al. Diagnosis of pancreatic disorders using contrast-enhanced endoscopic ultrasonography and endoscopic elastography. Clin. Gastroenterol. Hepatol. 2009; 7 (Suppl.): S6367.
  • 67
    Iglesias-Garcia J, Larino-Noia J, Abdulkader I, Forteza J, Dominguez-Munoz JE. EUS elastography for the characterization of solid pancreatic masses. Gastrointest. Endosc. 2009; 70: 11011108.
  • 68
    Giovannini M, Thomas B, Erwan B et al. Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study. World J. Gastroenterol. 2009; 15: 15871593.
  • 69
    Itokawa F, Itoi T, Sofuni A et al. EUS elastography combined with the strain ratio of tissue elasticity for diagnosis of solid pancreatic masses. J. Gastroenterol. 2011; 46: 843853.
  • 70
    Iglesias-Garcia J, Larino-Noia J, Abdulkader I, Forteza J, Dominguez-Munoz JE. Quantitative endoscopic ultrasound elastography: an accurate method for the differentiation of solid pancreatic masses. Gastroenterology 2010; 139: 11721180.
  • 71
    Saftoiu A, Vilmann P, Gorunescu F et al. Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic masses. Clin. Gastroenterol. Hepatol. 2012; 10: 8490 e1.
  • 72
    Norton ID, Zheng Y, Wiersema MS et al. Neural network analysis of EUS images to differentiate between pancreatic malignancy and pancreatitis. Gastrointest. Endosc. 2001; 54: 6167.
  • 73
    Das A, Nguyen CC, Li F et al. Digital image analysis of EUS images accurately differentiates pancreatic cancer from chronic pancreatitis and normal tissue. Gastrointest. Endosc. 2008; 67: 861867.
  • 74
    Khalid A, Zahir L, Bauer K et al. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am. J. Gastroenterol. 2006; 101: 24932500.
    Direct Link:
  • 75
    Khalid A, McGrath KM, Zahid M et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin. Gastroenterol. Hepatol. 2005; 3: 967973.